Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Glenmark Pharmaceuticals discloses new RORC antagonists

July 20, 2018

NT-1654 reduces clinical severity of EAMG in rats

July 20, 2018

Daiichi Sankyo and collaborator patent TNSALP inhibitors

July 19, 2018

Topline data presented from phase III trial of tanezumab

July 19, 2018

TAS-05567 selectively inhibits Syk kinase: potential treatment for autoimmune and allergic diseases

July 19, 2018

Audentes Therapeutics presents phase I/II data on AT-132 for XLMTM

July 13, 2018

FDA lifts clinical hold on Invossa trials

July 9, 2018

Bayer initiates first-in-human study with BAY-1830839

July 9, 2018

Neovacs reports phase IIb results for IFN-alpha kinoid in moderate to severe lupus

July 3, 2018

From Adam's rib to Miss Piggy's jaw

July 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...